We are live on ! Find out more
ADCT icon

ADC Therapeutics
ADCT

51 hedge funds and large institutions have $1.01B invested in ADC Therapeutics in 2020 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

23% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 13

10% more capital invested

Capital invested by funds: $921M → $1.01B (+$90.8M)

4.4% more ownership

Funds ownership: 36.79% → 41.19% (+4.4%)

7% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 15

2% less funds holding

Funds holding: 52 → 51 (-1)

63% less call options, than puts

Call options by funds: $227K | Put options by funds: $611K

Holders
51
Holders Change
-1
Holders Change %
-1.92%
% of All Funds
0.9%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.07%
New
14
Increased
16
Reduced
13
Closed
15
Calls
$227K
Puts
$611K
Net Calls
-$384K
Net Calls Change
-$51K

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$40.9M
2
JP Morgan Chase
JP Morgan Chase
New York
+$29.4M
3
AllianceBernstein
AllianceBernstein
Tennessee
+$16.5M
4
EAM
Eventide Asset Management
Massachusetts
+$16.2M
5
RG
Redmile Group
California
+$13.3M

Top Sellers

Rank Fund Capital Flow
1
MF
Magnetar Financial
Illinois
-$49.6M
2
DM
Deerfield Management
New York
-$9.9M
3
BBA
Baker Bros. Advisors
New York
-$8.83M
4
PI
PEAK6 Investments
Illinois
-$6.59M
5
IM
Islet Management
New York
-$6.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
26
Citadel Advisors
Florida
$2.72M +$2.78M +84,898 New
Rockefeller Capital Management
27
Rockefeller Capital Management
New York
$2.54M +$2.6M +79,397 New
Ameriprise
28
Ameriprise
Minnesota
$2.37M +$596K +18,177 +33%
Allianz Asset Management
29
Allianz Asset Management
Germany
$2M +$2.05M +62,590 New
Norges Bank
30
Norges Bank
Norway
$1.92M – – –
Marshall Wace
31
Marshall Wace
United Kingdom
$1.91M -$4.46M -136,085 -70%
TD Asset Management
32
TD Asset Management
Ontario, Canada
$1.68M +$1.72M +52,489 New
PI
33
PEAK6 Investments
Illinois
$1.02M -$6.59M -201,210 -86%
MWNA
34
Marshall Wace North America
New York
$962K -$1.5M -45,786 -60%
Millennium Management
35
Millennium Management
New York
$950K -$67.8K -2,068 -7%
Two Sigma Investments
36
Two Sigma Investments
New York
$704K +$721K +21,997 New
Zurich Cantonal Bank
37
Zurich Cantonal Bank
Switzerland
$685K +$702K +21,408 New
Victory Capital Management
38
Victory Capital Management
Texas
$556K -$40.7K -1,242 -7%
CF
39
CNA Financial
Illinois
$345K +$121K +3,690 +52%
PCM
40
Pentwater Capital Management
Florida
$320K – – –
VEA
41
Virtus ETF Advisers
New York
$276K +$282K +8,616 New
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
$275K +$282K +8,594 New
SFI
43
Susquehanna Fundamental Investments
Pennsylvania
$264K -$786K -23,978 -74%
TRCT
44
Tower Research Capital (TRC)
New York
$147K +$151K +4,603 New
AA
45
AlphaCentric Advisors
Puerto Rico
$112K +$81.9K +2,500 +250%
Bank of America
46
Bank of America
North Carolina
$77K -$49.2K -1,500 -38%
UBS Group
47
UBS Group
Switzerland
$47K +$43.4K +1,324 +939%
Group One Trading
48
Group One Trading
Illinois
$13K +$13.1K +400 New
Simplex Trading
49
Simplex Trading
Illinois
$9K -$4.36K -133 -30%
Osaic Holdings
50
Osaic Holdings
Arizona
$6K +$524 +16 +10%
1
2
3

ADCT Hedge Fund Activity: Q4 2020 in Review

51 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in ADC Therapeutics (ADCT) for Q4 2020, worth a combined $1.01B — up 9.9% from $921M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of ADCT and 14 opened new positions — a net loss of 1 holder — while 13 trimmed existing stakes and 16 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $40.9M. The largest seller was Magnetar Financial, cutting an estimated $49.6M.

  • 51 institutional investors held ADC Therapeutics (ADCT) as of Q4 2020, down from 52 in Q3 2020.
  • Funds reported $1.01B of ADC Therapeutics stock for Q4 2020, up 9.9% quarter-over-quarter.
  • 14 funds opened new ADC Therapeutics positions in Q4 2020 and 15 closed out, a net change of -1 holder.
  • The largest ADC Therapeutics buyer in Q4 2020 was T. Rowe Price Associates, an estimated $40.9M added.
  • The largest ADC Therapeutics seller in Q4 2020 was Magnetar Financial, an estimated $49.6M sold.

Based on aggregated 13F filings for Q4 2020.